Debjit Chattopadhyay
Stock Analyst at Guggenheim
(4.52)
# 277
Out of 5,140 analysts
112
Total ratings
57.28%
Success rate
20.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $64 → $52 | $22.63 | +129.78% | 4 | Jan 5, 2026 | |
| RZLT Rezolute | Maintains: Buy | $15 → $6 | $2.89 | +107.61% | 4 | Dec 12, 2025 | |
| PHVS Pharvaris | Maintains: Buy | $32 → $39 | $26.21 | +48.80% | 1 | Dec 4, 2025 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $28 → $43 | $22.92 | +87.61% | 8 | Nov 18, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $22 → $19 | $21.04 | -9.70% | 7 | Nov 5, 2025 | |
| LXEO Lexeo Therapeutics | Initiates: Buy | $30 | $7.26 | +313.22% | 1 | Oct 15, 2025 | |
| QURE uniQure | Maintains: Buy | $28 → $95 | $22.40 | +324.11% | 7 | Sep 25, 2025 | |
| PEPG PepGen | Reiterates: Buy | $6 | $5.95 | +0.84% | 2 | Sep 24, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $90 → $92 | $77.53 | +18.66% | 6 | Sep 23, 2025 | |
| MAZE Maze Therapeutics | Maintains: Buy | $19 → $34 | $44.34 | -23.32% | 3 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $106 | $43.73 | +142.40% | 5 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $10 | $12.77 | -21.69% | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $14 | $12.83 | +9.12% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $106 | $56.31 | +88.24% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $558 → $546 | $442.08 | +23.51% | 8 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $16.58 | +201.57% | 5 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $189 | $274.73 | -31.21% | 4 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $55 | $30.97 | +77.62% | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $3.89 | +362.72% | 3 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $11.56 | +47.06% | 2 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $14.31 | +4.82% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Neutral | n/a | $52.61 | - | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $4.17 | +355.64% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $3.67 | +499.46% | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $32.41 | -7.44% | 1 | Jan 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $29 | $1.57 | +1,747.13% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $355.53 | - | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $4.64 | +503.45% | 1 | Dec 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $20 | $13.82 | +44.72% | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $270 → $123 | $33.50 | +267.16% | 8 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $54 | $23.67 | +128.14% | 3 | Jul 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $60 | $1.23 | +4,778.05% | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $26.68 | - | 3 | Jun 26, 2017 |
Ultragenyx Pharmaceutical
Jan 5, 2026
Maintains: Buy
Price Target: $64 → $52
Current: $22.63
Upside: +129.78%
Rezolute
Dec 12, 2025
Maintains: Buy
Price Target: $15 → $6
Current: $2.89
Upside: +107.61%
Pharvaris
Dec 4, 2025
Maintains: Buy
Price Target: $32 → $39
Current: $26.21
Upside: +48.80%
Centessa Pharmaceuticals
Nov 18, 2025
Maintains: Buy
Price Target: $28 → $43
Current: $22.92
Upside: +87.61%
Sarepta Therapeutics
Nov 5, 2025
Maintains: Buy
Price Target: $22 → $19
Current: $21.04
Upside: -9.70%
Lexeo Therapeutics
Oct 15, 2025
Initiates: Buy
Price Target: $30
Current: $7.26
Upside: +313.22%
uniQure
Sep 25, 2025
Maintains: Buy
Price Target: $28 → $95
Current: $22.40
Upside: +324.11%
PepGen
Sep 24, 2025
Reiterates: Buy
Price Target: $6
Current: $5.95
Upside: +0.84%
Ionis Pharmaceuticals
Sep 23, 2025
Maintains: Buy
Price Target: $90 → $92
Current: $77.53
Upside: +18.66%
Maze Therapeutics
Sep 15, 2025
Maintains: Buy
Price Target: $19 → $34
Current: $44.34
Upside: -23.32%
Aug 27, 2025
Reiterates: Buy
Price Target: $106
Current: $43.73
Upside: +142.40%
Aug 14, 2025
Maintains: Buy
Price Target: $40 → $10
Current: $12.77
Upside: -21.69%
Aug 13, 2025
Maintains: Buy
Price Target: $45 → $14
Current: $12.83
Upside: +9.12%
Aug 6, 2025
Maintains: Buy
Price Target: $101 → $106
Current: $56.31
Upside: +88.24%
Aug 6, 2025
Maintains: Buy
Price Target: $558 → $546
Current: $442.08
Upside: +23.51%
Jun 18, 2025
Reiterates: Buy
Price Target: $50
Current: $16.58
Upside: +201.57%
May 7, 2025
Maintains: Buy
Price Target: $195 → $189
Current: $274.73
Upside: -31.21%
May 7, 2025
Maintains: Buy
Price Target: $78 → $55
Current: $30.97
Upside: +77.62%
Dec 3, 2024
Reiterates: Buy
Price Target: $18
Current: $3.89
Upside: +362.72%
Dec 3, 2024
Reiterates: Buy
Price Target: $17
Current: $11.56
Upside: +47.06%
Nov 7, 2024
Maintains: Buy
Price Target: $13 → $15
Current: $14.31
Upside: +4.82%
Jun 28, 2024
Assumes: Neutral
Price Target: n/a
Current: $52.61
Upside: -
Apr 30, 2024
Initiates: Buy
Price Target: $19
Current: $4.17
Upside: +355.64%
Mar 26, 2024
Initiates: Buy
Price Target: $22
Current: $3.67
Upside: +499.46%
Jan 18, 2024
Initiates: Buy
Price Target: $30
Current: $32.41
Upside: -7.44%
Nov 21, 2022
Maintains: Buy
Price Target: $43 → $29
Current: $1.57
Upside: +1,747.13%
Jun 27, 2022
Downgrades: Neutral
Price Target: n/a
Current: $355.53
Upside: -
Dec 16, 2021
Initiates: Buy
Price Target: $28
Current: $4.64
Upside: +503.45%
Dec 15, 2020
Assumes: Buy
Price Target: $20
Current: $13.82
Upside: +44.72%
Aug 24, 2020
Downgrades: Neutral
Price Target: $270 → $123
Current: $33.50
Upside: +267.16%
Jul 9, 2020
Maintains: Buy
Price Target: $60 → $54
Current: $23.67
Upside: +128.14%
Dec 3, 2019
Downgrades: Neutral
Price Target: $60
Current: $1.23
Upside: +4,778.05%
Jun 26, 2017
Downgrades: Neutral
Price Target: n/a
Current: $26.68
Upside: -